Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigensShengle Zhang, Philip O. Livingston, Carlos Cordon‐Cardo et al.|International Journal of Cancer|1997Cited by 294
Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosidesShengle Zhang, Philip O. Livingston, Carlos Cordon‐Cardo et al.|International Journal of Cancer|1997Cited by 278
Selective CD4<sup>+</sup> Lymphopenia in Melanoma Patients Treated With Temozolomide: A Toxicity With Therapeutic ImplicationsY.B. Su, Paul B. Chapman, SeJean Sohn et al.|Journal of Clinical Oncology|2004Cited by 258
Carbohydrate vaccines in cancer: Immunogenicity of a fully synthetic globo H hexasaccharide conjugate in manSusan F. Slovin, Howard I. Scher, Govindaswami Ragupathi et al.|Proceedings of the National Academy of Sciences|1999Cited by 253
Ganglioside expression on human malignant melanoma assessed by quantitative immune thin‐layer chromatographyWm. Bradley Hamilton, Philip O. Livingston, Friedhelm Helling et al.|International Journal of Cancer|1993Cited by 156